glp-1 long-term risks Success of GLP-1s Hinges on More Than Just a Prescription Long-term cancer risk in users
Description
Try over-the-counter medication If lifestyle changes arent enough, theres still hope
P = 0.54
The decision is primarily driven by rising costs, with BCBS MA reporting a $400 million operating loss in 2024, partly due to spending on GLP-1 drugs
The FDA has raised specific concerns about compounded semaglutide products, including reports of adverse events tied to dosing errors and concerns about the use of salt forms not present in FDA-approved formulations
